ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,304.72
      0.70%
      US Tech 100
      18,318.00
      0.95%
      Dow Jones
      39,069.59
      0.01%
      Brent Oil
      81.965
      0.00%
      Bitcoin
      69,150.37
      -0.17%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. UK
      5. LSE
      6. Maxcyte Inc (MXCT)

      7. Maxcyte Inc (MXCT) News

      MXCT Maxcyte Inc

      365.00
      -2.00 (-0.54%)
      May 24 2024 - Closed
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      Maxcyte Inc MXCT London Ordinary Share
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      -2.00 -0.54% 365.00 03:00:00
      Open Price Low Price High Price Close Price Prev Close
      365.00 365.00 365.00 365.00 367.00
      more quote information »
      Industry Sector
      PHARMACEUTICALS & BIOTECHNOLOGY

      Recent News

      Date Time Source Heading
      5/22/202416:51ALNCNewsIN BRIEF: MaxCyte inks deal with Legend Biotech for tech..
      5/22/202408:05GLOBEMaxCyte Signs Strategic Platform License Agreement with..
      5/22/202408:05UK RNSMaxCyte, Inc. Signing of Strategic Platform License
      5/20/202402:00UK RNSMaxCyte, Inc. Holding(s) in Company
      5/14/202409:55UK RNSMaxCyte, Inc. Holding(s) in Company
      5/08/202404:46ALNCNewsMaxCyte shares rise amid double-digit revenue increase
      5/08/202402:05UK RNSMaxCyte, Inc. Filing of Form 10-Q
      5/08/202402:00UK RNSMaxCyte, Inc. First Quarter Results
      5/07/202416:05GLOBEMaxCyte Reports First Quarter 2024 Financial Results and..
      5/03/202402:00UK RNSMaxCyte, Inc. Notice of AGM
      5/01/202412:04UK RNSMaxCyte, Inc. Total Voting Rights
      4/10/202408:05GLOBEMaxCyte to Report First Quarter 2024 Financial Results on..
      4/10/202408:05UK RNSMaxCyte, Inc. Notice of Results
      4/03/202402:00UK RNSMaxCyte, Inc. Total Voting Rights and Block Listing Return
      4/02/202410:19ALNCNewsTRADING UPDATES: MaxCyte inks deal with Be Bio; Orcadian..
      4/02/202408:05UK RNSMaxCyte, Inc. Signing of Strategic Platform License
      4/02/202408:05GLOBEMaxCyte Signs Strategic Platform License with Be Biopharma..
      4/02/202402:00UK RNSMaxCyte, Inc. Exercise of options and PDMR dealing
      3/20/202406:16UK RNSMaxCyte, Inc. Grant of Options, RSUs and PSUs and PDMR..
      3/20/202406:05UK RNSMaxCyte, Inc. Grant of Options, RSUs and PSUs and PDMR..
      3/13/202407:54ALNCNewsIN BRIEF: MaxCyte loss widens in 2023 as core revenue..
      3/13/202403:05UK RNSMaxCyte, Inc. Filing of form 10-K for FY ended December 31,..
      3/13/202403:00UK RNSMaxCyte, Inc. Reports Q4 & FY 2023 Financial Results
      3/12/202416:05UKREGMaxCyte Reports Fourth Quarter and Full Year 2023 Financial..
      3/06/202403:58UK RNSMaxCyte, Inc. TR-1: Notification of major holdings
      3/05/202415:43ALNCNewsEARNINGS: dotdigital eyes rosy future; Beeks Financial turns..
      3/05/202402:00UK RNSMaxCyte, Inc. Preliminary FY Results & 2024 Guidance
      3/04/202416:05UKREGMaxCyte Initiates Full Year 2024 Guidance and Reaffirms 2023..
      3/01/202412:57UK RNSMaxCyte, Inc. Total Voting Rights
      2/29/202404:21UK RNSMaxCyte, Inc. Exercise of options and PDMR dealing
      2/26/202402:00UK RNSMaxCyte, Inc. TR-1: Notification of major holdings
      2/09/202408:05UK RNSMaxCyte, Inc. Notice of Results
      2/09/202408:05UKREGMaxCyte to Report Fourth Quarter and Full Year 2023..
      2/01/202404:24UK RNSMaxCyte, Inc. Total Voting Rights
      1/31/202402:00UK RNSMaxCyte, Inc. Director/PDMR Shareholding
      1/30/202409:29UK RNSMaxCyte, Inc. Holding(s) in Company
      1/30/202408:58ALNCNewsIN BRIEF: MaxCyte signs licencing deal with cell therapy..
      1/30/202408:05UKREGMaxCyte and Wugen Sign Strategic Platform License to..
      1/30/202408:05UK RNSMaxCyte, Inc. Signing of Strategic Platform License
      1/29/202412:56ALNCNewsIN BRIEF: MaxCyte chief scientific officer leaves firm
      1/29/202411:52UK RNSMaxCyte, Inc. TR-1: Notification of major holdings
      1/29/202402:00UK RNSMaxCyte, Inc. Filing of Form 8-K
      1/23/202413:39ALNCNewsTRADING UPDATES: Esken's Southend Airport faces further..
      1/23/202408:05UKREGMaxCyte, Inc. Signing of Strategic Platform License
      1/23/202408:05GLOBEMaxCyte Signs Strategic Platform License with Imugene to..
      1/09/202407:18ALNCNewsMaxCyte's strategic platform licences redeem otherwise..
      1/09/202402:00UKREGMaxCyte, Inc. Preliminary Unaudited Q4 and FY 2023 Results
      1/08/202416:05GLOBEMaxCyte Announces Preliminary Unaudited Fourth Quarter and..
      1/05/202402:00UKREGMaxCyte, Inc. Grant of Options and PDMR Dealing
      1/03/202409:04ALNCNewsMaxCyte teams with Singapore-based Lion to support TCR-T..

      Your Recent History

      LSE
      MXCT
      Maxcyte
      Delayed Upgrade Clock